Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 3/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | BRD4 | O60885 | 2/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102517 | 0.97 | GRM2 (0.32) | GRM2PDE10AHTR2AHTR2CHTR2B | |
| SCHEMBL20102614 | 0.91 | HTR2A (0.31) | GRM2HTR2AHTR2CHTR2BBRD4 | |
| SCHEMBL20102604 | 0.91 | HTR2A (0.31) | GRM2HTR2AHTR2CHTR2BBRD4 | |
| SCHEMBL20102590 | 0.90 | — | — | |
| SCHEMBL20102519 | 0.89 | HTR2A (0.34) | PDE10AHTR2AHTR2CHTR2BBRD4 | |
| SCHEMBL20102546 | 0.89 | PPARG (0.31) | HTR2AHTR2CHTR2B | |
| SCHEMBL20102585 | 0.88 | RIPK1 (0.31) | RIPK1 | |
| SCHEMBL20102396 | 0.86 | HTR2A (0.32) | GRM2HTR2AHTR2CHTR2BBRD4 | |
| SCHEMBL20102571 | 0.86 | HTR2A (0.32) | GRM2HTR2AHTR2CHTR2BBRD4 | |
| SCHEMBL20102524 | 0.86 | EPHX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX1, PIEZO1, C1S | GRM2 3967/4885PDE10A 1161/4885HTR2A 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.